Search Results - "Umberto Capece"
-
1
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features
Published in Nutrients (21-12-2022)“…Alpha-lipoic acid (ALA) is a natural compound with antioxidant and pro-oxidant properties which has effects on the regulation of insulin sensitivity and…”
Get full text
Journal Article -
2
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report
Published in Cardiovascular diabetology (03-09-2022)“…Abstract Objective Cardiovascular (CV) outcome trials have shown that in patients with type 2 diabetes (T2D), treatment with sodium-glucose cotransporter-2…”
Get full text
Journal Article -
3
Real-world evidence evaluation of LDL-C in hospitalized patients: a population-based observational study in the timeframe 2021-2022
Published in Lipids in health and disease (24-07-2024)“…European registries and retrospective cohort studies have highlighted the failure to achieve low-density lipoprotein-cholesterol (LDL-C) targets in many very…”
Get full text
Journal Article -
4
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function
Published in Nutrients (28-09-2023)“…Type 2 diabetes mellitus (T2DM) is one of the most widespread diseases worldwide. Lifestyle interventions, including diet and physical activity (PA), are…”
Get full text
Journal Article -
5
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes
Published in Cardiovascular diabetology (19-12-2023)“…We recently demonstrated that treatment with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) leads to an increase in myocardial flow reserve in patients…”
Get full text
Journal Article -
6
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study
Published in Frontiers in endocrinology (Lausanne) (31-05-2023)“…Anti-PCSK9 monoclonal antibodies are effective in reducing LDL-C and cardiovascular events by neutralizing circulating PCSK9. PCSK9, however, is also expressed…”
Get full text
Journal Article -
7
Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis
Published in The journal of clinical endocrinology and metabolism (01-07-2019)“…Abstract Objective Changes in bile flow after bariatric surgery may beneficially modulate secretion of insulin and incretins, leading to diabetes remission…”
Get full text
Journal Article -
8
1535-P: Type 2 Diabetes Remission after Roux-en-Y Gastric Bypass Is Related to a Reduction of Pancreatic Noradrenergic Innervation and Beta-Cell Redifferentiation
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Background: β cell dedifferentiation has been identified as the process responsible for the functional "disappearance" of β cells from the islets of diabetic…”
Get full text
Journal Article -
9
140-OR: The Coronary Flow Reserve Increase after Dapagliflozin Treatment in Patients with Type 2 Diabetes Is Maintained after Four Years-A Four-Year DAPAHEART Follow-up Study
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction & Objective: Cardiovascular (CV) outcome trials have shown that in patients with type 2 diabetes (T2D), treatment with sodium-glucose…”
Get full text
Journal Article -
10
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes
Published in The Journal of clinical investigation (15-06-2021)“…BACKGROUND. The appearance of hyperglycemia is due to insulin resistance, functional deficits in the secretion of insulin, and a reduction of ß cell mass…”
Get full text
Journal Article -
11
First-phase insulin secretion: can its evaluation direct therapeutic approaches?
Published in Trends in endocrinology and metabolism (01-04-2023)“…β Cells can adapt to pathological metabolic conditions by implementing plasticity mechanisms to increase their mass and enhance insulin secretion, thus…”
Get full text
Journal Article -
12
Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes
Published in The Journal of clinical investigation (15-04-2024)Get full text
Journal Article -
13
1068-P: Reassessing Insulin Therapy In Diabetes of the Exocrine Pancreas-A Pilot Study
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Cohort studies have demonstrated that subjects with diabetes of the exocrine pancreas (DEP) are mostly treated with basal bolus insulin. To reassess insulin…”
Get full text
Journal Article -
14
The interlink between thyroid autoimmunity and type 1 diabetes and the impact on male and female fertility
Published in Hormones (Athens, Greece) (01-09-2024)“…The aim of this review is to discuss the several interconnections between thyroid autoimmunity and type 1 diabetes in terms of epidemiology, immunoserology,…”
Get full text
Journal Article -
15
1754-P: Reduced Incretin Effect Predicts Diabetes Appearance in a Cohort of Nondiabetic Subjects after Acute Beta-Cell Mass Reduction
Published in Diabetes (New York, N.Y.) (20-06-2023)“…In type 2 diabetes incretin effect (IE) is reduced but still contributes to 20-35% of insulin response to oral glucose. One reason is the impairment of GIP and…”
Get full text
Journal Article -
16
2110-P: Correlation between Ex Vivo Islet Proteomic Analysis and In Vivo Secretory Function in Humans
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Insulin resistance and β-cell dysfunction are the main actors in the pathogenesis of type 2 diabetes mellitus, causing both quantitative and qualitative loss…”
Get full text
Journal Article -
17
Beta-cell function and glucose metabolism in patients with chronic pancreatitis
Published in European journal of internal medicine (01-10-2024)“…•Chronic pancreatitis is the most frequent cause of diabetes secondary to pancreatic disease.•Alterations in insulin secretion can only be detected by…”
Get full text
Journal Article -
18
134-OR: Effects of PCSK9 Inhibitors on Glucose Metabolism and ß-Cell Function in Humans
Published in Diabetes (New York, N.Y.) (01-06-2020)“…PCSK9 inhibitors are monoclonal antibodies effective in reducing LDL-C and cardiovascular events by neutralizing circulating PCSK9. Since PCSK9 is also…”
Get full text
Journal Article -
19
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional [beta] cells in predicting diabetes
Published in The Journal of clinical investigation (15-06-2021)“…BACKGROUND. The appearance of hyperglycemia is due to insulin resistance, functional deficits in the secretion of insulin, and a reduction of [beta] cell mass…”
Get full text
Journal Article -
20
2295-PUB: Impaired First-Phase Insulin Secretion Predicts the Development of Hyperglycemia in a Human Model of Acute Beta-Cell Mass Reduction
Published in Diabetes (New York, N.Y.) (01-06-2020)“…β-cell functional defects temporally anticipate (and eventually cause) the subsequent development of hyperglycemia, whereas a significant reduction (∼50%) of…”
Get full text
Journal Article